Search Results - Surai, Anton

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Silymarin and Inflammation: Food for Thoughts

    Silymarin and Inflammation: Food for Thoughts by Surai, Peter F, Surai, Anton, Earle-Payne, Katie

    Published in Antioxidants
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

    Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1... by Palanca-Wessels, Maria Corinna A, Dr, Czuczman, Myron, Prof, Salles, Gilles, Prof, Assouline, Sarit, MD, Sehn, Laurie H, MD, Flinn, Ian, MD, Patel, Manish R, MD, Sangha, Randeep, MD, Hagenbeek, Anton, MD, Advani, Ranjana, MD, Tilly, Herve, Prof, Casasnovas, Olivier, MD, Press, Oliver W, Prof, Yalamanchili, Sreeni, PharmD, Kahn, Robert, MD, Dere, Randall C, BSc, Lu, Dan, PhD, Jones, Surai, MS, Jones, Cheryl, ScD, Chu, Yu-Waye, MD, Morschhauser, Franck, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers

    Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers by Jhaveri, Komal, Chang, Matthew T, Juric, Dejan, Saura, Cristina, Gambardella, Valentina, Melnyk, Anton, Patel, Manish R, Ribrag, Vincent, Ma, Cynthia X, Aljumaily, Raid, Bedard, Philippe L, Sachdev, Jasgit C, Dunn, Lara, Won, Helen, Bond, John, Jones, Surai, Savage, Heidi M, Scaltriti, Maurizio, Wilson, Timothy R, Wei, Michael C, Hyman, David M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract CT046: A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA -mutated locally advanced or metastatic solid tumors

    Abstract CT046: A phase I basket study of the PI3K inhibitor taselisib (GDC-0032) in PIK3CA -mutated locally advanced or metastatic solid tumors by Jhaveri, Komal, Juric, Dejan, Saura, Cristina, Cervantes, Andrés, Melnyk, Anton, Patel, Manish R., Oliveira, Mafalda, Gambardella, Valentina, Ribrag, Vincent, Ma, Cynthia X., Aljumaily, Raid, Bedard, Philippe L., Sachdev, Jasgit C., Bond, John, Jones, Surai, Wilson, Timothy R., Wei, Michael C., Baselga, José

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

    Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma by Morschhauser, Franck, Flinn, Ian, Advani, Ranjana H, Diefenbach, Catherine S., Kolibaba, Kathryn, Press, Oliver W., Sehn, Laurie H, Chen, Andy I, Salles, Gilles, Tilly, Herve, Cheson, Bruce D., Assouline, Sarit, Dreyling, Martin, Hagenbeek, Anton, Zinzani, Pier Luigi, Yalamanchili, Sreeni, Lu, Dan, Jones, Cheryl, Jones, Surai, Chu, Yu-Waye, Sharman, Jeff P.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: